CLINICAL_TRIALS
trial_result
· 2023-11-01
Clinical Trial Update: Efficacy and Safety of BN101 in Subjects With Chronic Graft Versus Host Disease (cGVHD) [Phase 2]
Summary
Phase 2 trial update assessing efficacy and safety of BN101 in subjects with chronic graft-versus-host disease (cGVHD).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: BioNova Pharmaceuticals (Shanghai) LTD. | Conditions: GVHD, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2023-11-01